Item 1.01 중요

중요 계약 체결

Item 1.01 Entry into a Material Definitive Agreement.   On June 25, 2026, Bio-Techne Corporation, a Minnesota corporation (the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Merck KGaA, Darmstadt, Germany, a German corporation with general partners (“ Parent ”), and EMD Holdings NewCo, Inc., a Minnesota corporation and a wholly-owned subsidiary of Parent (“ Merger Sub ”). The Merger Agreement provides that, on the terms and subject to the conditions...

Item 5.02 중요

임원 변동

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.   On June 23, 2026, in connection with the contemplated Merger, the Compensation Committee of the Board (the “ Compensation Committee ”) approved cash retention bonus awards to each of the Company’s current named executive officers pursuant to retention agreements (the “ Retention Agreements ”) in order to encourage the Company’s named ...